These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6353086)

  • 1. [Pancreatic function and thyroid hormones].
    Salmerón de Diego J
    Med Clin (Barc); 1983 Jun; 81(2):51-2. PubMed ID: 6353086
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radioimmunoassay in endocrinology].
    Ametov AS; Toritsina LK
    Med Radiol (Mosk); 1983 Aug; 28(8):76-83. PubMed ID: 6412030
    [No Abstract]   [Full Text] [Related]  

  • 3. More on thyroid status in patients with chronic renal failure: effect of glucose intolerance on serum reverse T3.
    De Marchi S; Cecchin E; Tesio F; Borean M
    Clin Nephrol; 1984 May; 21(5):303-4. PubMed ID: 6734000
    [No Abstract]   [Full Text] [Related]  

  • 4. Very early changes in circulating T3 and rT3 during development of metabolic derangement in diabetic patients.
    Madsbad S; Laurberg P; Weeke J; Orskov H; Faber OK; Binder C; Krarup T; Regeur L
    Acta Med Scand; 1981; 209(5):385-7. PubMed ID: 7018180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pancreatic beta-cell function in Itsenko-Cushing disease].
    Slavnov VN; Komissarenko IV; Eremenko NI
    Vrach Delo; 1983 Nov; (11):79-82. PubMed ID: 6362198
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diabetes mellitus in patients with chronic alcoholic pancreatitis].
    Sadokov VM; Vinokurova LV
    Ter Arkh; 1993; 65(10):27-9. PubMed ID: 8296228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes mellitus and thyroid diseases].
    Lopatyński J
    Pol Tyg Lek; 1980 Apr; 35(16):591-4. PubMed ID: 6994071
    [No Abstract]   [Full Text] [Related]  

  • 9. [Functional activity of the insular apparatus of the pancreas in children with newly diagnosed diabetes mellitus].
    Shcherbacheva LN; Lobanova AM; Arbuzova MI
    Pediatriia; 1989; (11):10-4. PubMed ID: 2691976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term changes in levels of circulating T3 and reverse T3 in type 1 (insulin-dependent) diabetic patients.
    Madsbad S
    Diabetologia; 1983 Feb; 24(2):137-8. PubMed ID: 6840424
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].
    Faber OK
    Ugeskr Laeger; 1980 Jan; 142(4):215-21. PubMed ID: 6986696
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood serum C-peptide level after arginine stimulation in the early and later stage of insulin-dependent diabetes].
    Miedzińska-Szadkowska E; Lawecki J; Symonides-Lawecka A
    Pol Arch Med Wewn; 1980 Nov; 64(5):421-9. PubMed ID: 7012801
    [No Abstract]   [Full Text] [Related]  

  • 13. [Islet beta-cell function in failures following sulfonylurea therapy in diabetics, by determination of serum C-peptide].
    Costamaillere L; Arteaga A; Velasco N; Pellegrino MR; Foradori A; López G; Acosta AM
    Rev Med Chil; 1984 Dec; 112(12):1206-13. PubMed ID: 6399604
    [No Abstract]   [Full Text] [Related]  

  • 14. [Usefulness of the determination of C-peptide and proinsulin in the extrahepatic serum for the evaluation of the function of the B cells of the islands of Langerhans].
    Czyzyk A
    Pol Arch Med Wewn; 1983; 69(4-5):249-57. PubMed ID: 6356053
    [No Abstract]   [Full Text] [Related]  

  • 15. [The occurrence of proinsulin and C-peptide in healthy humans and in diabetics].
    Beischer W
    Fortschr Med; 1982 Sep; 100(33):1508-12. PubMed ID: 7129312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pancreatic beta cell function and the C-peptide content in the blood serum in thyrotoxicosis].
    Pavliuk PM; Slavnov VN; Epshteĭn EV
    Klin Med (Mosk); 1982 Apr; 60(4):51-4. PubMed ID: 7047893
    [No Abstract]   [Full Text] [Related]  

  • 17. C-peptide and free insulin determinations in type I diabetes; relationships with metabolic control and insulin therapy.
    Taskinen MR; Groop L
    Ann Clin Res; 1984; 16(2):118-27. PubMed ID: 6380385
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathophysiology and treatment of pancreatic diabetes].
    Hayakawa T
    Kango Gijutsu; 1985 May; 31(7):885-8. PubMed ID: 3906207
    [No Abstract]   [Full Text] [Related]  

  • 19. Residual beta-cell function and its metabolic consequences.
    Binder C; Faber OK
    Diabetes; 1978; 27 Suppl 1():226-9. PubMed ID: 344113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the measurement of reverse T3 in suspected thyroid disease.
    Dalton A; Standing S; Lacey RW
    Med Lab Sci; 1983 Jul; 40(3):235-42. PubMed ID: 6621267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.